. Author manuscript; available in PMC: 2023 Oct 18.

Published in final edited form as: Int J Gynecol Cancer. 2023 Aug 7;33(8):1203–1207. doi: 10.1136/ijgc-2023-004324

Table 2:

Publications within 3 years of SGO Annual Meeting per funding type and study design between 2017 and 2018

	Podium Presentations Published within 3 years
	2017	2018	2017–2018
FUNDING SUBTYPES
NIH	15 (34.9%)	14 (29.8%)	29 (32.2%)
NON-NIH	7 (16.2%)	12 (25.5%)	19 (21.1%)
NONE	16 (38.1%)	11 (23.4%)	27 (30.0%)
PHARMACEUTICAL	5 (11.6%)	10 (21.3%)	15 (16.7%)
STUDY DESIGN SUBTYPES
EXPERIMENTAL	8 (18.6%)	15 (31.9%)	23 (25.6%)
NON-EXPERIEMENTAL	25 (58.1%)	27 (57.3%)	52 (83.3%)
PRE-CLINICAL RESEARCH	10 (23.3%)	5 (10.6%)	15 (16.7%)
TOTAL	43	47	90

Table demonstrates the publication rates segregated by year and subdivided to include the following: funding and study design sub-types.